4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-009484
President sold 30,000 shares at an average $62.25 ($1,867,532)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-08 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2021-02-08 | Sale | −10,656 | $61.96 | $660,246 | 4,344 | D |
| RUBINSTEIN JULIE President | 2021-02-08 | Sale | −4,344 | $62.43 | $271,196 | 0 | D |
| RUBINSTEIN JULIE President | 2021-02-09 | Option exercise | +10,000 | $6.55 | $65,500 | 10,000 | D |
| RUBINSTEIN JULIE President | 2021-02-09 | Option exercise | +5,000 | $6.32 | $31,600 | 15,000 | D |
| RUBINSTEIN JULIE President | 2021-02-09 | Sale | −7,611 | $61.81 | $470,436 | 7,389 | D |
| RUBINSTEIN JULIE President | 2021-02-09 | Sale | −7,389 | $63.02 | $465,655 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2021-02-08 | Option exercise · Stock Option (Right to Buy) | −15,000 | 5,000 | D | ||
| RUBINSTEIN JULIE President | 2021-02-09 | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | D | ||
| RUBINSTEIN JULIE President | 2021-02-09 | Option exercise · Stock Option (Right to Buy) | −10,000 | 390,000 | D | ||
| Open-market sales · 30,000 sh · avg $62.25 · $1,867,532 | |||||||
Loading xslF345X03/doc4.xml…